sur BASTIDE (EPA:BLC)
Groupe Bastide Sells New Medical Concept to Sapio Group
On May 21, 2026, Groupe Bastide announced the sale of its subsidiary, New Medical Concept, the holding company of the EXPERF group, to Sapio Group. EXPERF, specializing in home infusion and clinical nutrition care, has doubled its revenue since its acquisition in 2017, reaching €42 million in the 2024-2025 financial year.
This transaction aligns with Groupe Bastide's strategy of asset rotation and financial strengthening. The sale is expected to reduce financial expenses and improve the financial leverage ratio to above 2.5x post-transaction. However, it will not impact the company’s reported revenue for the current financial year.
Sapio Group's CEO, Mario Paterlini, noted that acquiring EXPERF is crucial for their growth in the European healthcare market. The deal awaits customary closing conditions.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BASTIDE